Company profile OMGA

Omega Therapeutics Inc
omega therapeutics™ is a preclinical stage genomic medicine enterprise transforming medicine and patient care through precision genomic control. the company’s platform is focused on selectively directing the human genome to treat and cure disease by precisely controlling genomic expression without changing nucleic acid sequences. we are developing precision therapeutics for... a range of disease indications including rare genetic diseases, immunology, inflammation, metabolic diseases and oncology. # transformativemedicines #pioneeringmedicines Show More
Quarter analysis & expected interestLast update: February 08 2024 01:48:48.

After 38 days of this quarter the interest is at 143.0. Based on that we can calculate that during remaining 53 days it will total up to 342.0.
omega therapeutics expected interest is significantly higher compared to previous quarter (+362.2%) and same quarter last year (+402.9%).

YearQ1Q2Q3Q4
201914
15
7.1% QoQ
23
53.3% QoQ
21
-8.7% QoQ
2020 48
242.9% YoY 128.6% QoQ
37
146.7% YoY -22.9% QoQ
57
147.8% YoY 54.1% QoQ
10
-52.4% YoY -82.5% QoQ
2021 21
-56.2% YoY 110.0% QoQ
62
67.6% YoY 195.2% QoQ
124
117.5% YoY 100.0% QoQ
64
540.0% YoY -48.4% QoQ
2022 68
223.8% YoY 6.2% QoQ
80
29.0% YoY 17.6% QoQ
59
-52.4% YoY -26.2% QoQ
67
4.7% YoY 13.6% QoQ
2023 68
0.0% YoY 1.5% QoQ
62
-22.5% YoY -8.8% QoQ
46
-22.0% YoY -25.8% QoQ
74
10.4% YoY 60.9% QoQ
2024 143
110.3% YoY 93.2% QoQ
- - -
this symbol represents interest this quarter up to now and updates daily. For expected interest by the end of the quarter based on current trend see "Quarter analysis" above the table.
Correlation between past revenue and omega therapeutics search interestLast update: February 08 2024 01:48:48.
Correlation coefficient between keyword and revenue is -0.41
Interest value is multiplied to fit the chart properly. Correlation level is represented by Pearson correlation coefficient. Value closer to 1 represents higher level of correlation. Value closer to -1 represents inverted relationship. Value closer to 0 represents no relationship.
Analysis of YoY 5Y Google Trends Last update: February 08 2024 01:48:48.

The average 5 years interest of omega therapeutics was 4.46 per week.
The last year interest of omega therapeutics compared to the last 5 years has changed by 54.71%.
This is something to be checked.
The last year interest is quite higher compared to 5 years ago. It has increased by 252.04%.

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interestLast update: February 08 2024 01:48:52.

After 38 days of this quarter the interest is at 73.0. Based on that we can calculate that during remaining 53 days it will total up to 175.0.
That appears to be equal to previous quarter and same quarter last year.

YearQ1Q2Q3Q4
201935
75
114.3% QoQ
24
-68.0% QoQ
53
120.8% QoQ
2020 172
391.4% YoY 224.5% QoQ
50
-33.3% YoY -70.9% QoQ
152
533.3% YoY 204.0% QoQ
62
17.0% YoY -59.2% QoQ
2021 72
-58.1% YoY 16.1% QoQ
91
82.0% YoY 26.4% QoQ
34
-77.6% YoY -62.6% QoQ
58
-6.5% YoY 70.6% QoQ
2022 59
-18.1% YoY 1.7% QoQ
99
8.8% YoY 67.8% QoQ
0
-100.0% YoY -100.0% QoQ
94
62.1% YoY inf% QoQ
2023 138
133.9% YoY 46.8% QoQ
154
55.6% YoY 11.6% QoQ
82
inf% YoY -46.8% QoQ
136
44.7% YoY 65.9% QoQ
2024 73
-47.1% YoY -46.3% QoQ
- - -
this symbol represents interest this quarter up to now and updates daily. For expected interest by the end of the quarter based on current trend see "Quarter analysis" above the table.
Correlation between past revenue and omega therapeutics stock search interestLast update: February 08 2024 01:48:51.
Correlation coefficient between keyword and revenue is 0.32
Interest value is multiplied to fit the chart properly. Correlation level is represented by Pearson correlation coefficient. Value closer to 1 represents higher level of correlation. Value closer to -1 represents inverted relationship. Value closer to 0 represents no relationship.
Analysis of YoY 5Y Google Trends Last update: February 08 2024 01:48:53.

The average 5 years interest of omega therapeutics stock was 6.56 per week.
The last year interest of omega therapeutics stock compared to the last 5 years has changed by 35.21%.
This is something to be checked.
The last year interest is quite higher compared to 5 years ago. It has increased by 41.47%.

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for omega therapeutics news to provide analysis

Correlation between past revenue and omega therapeutics news search interest

There is not enough data for omega therapeutics news to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for omega therapeutics news to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for cambridge biotechnology companies to provide analysis

Correlation between past revenue and cambridge biotechnology companies search interest

There is not enough data for cambridge biotechnology companies to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for cambridge biotechnology companies to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for omega therapeutics clinical trials to provide analysis

Correlation between past revenue and omega therapeutics clinical trials search interest

There is not enough data for omega therapeutics clinical trials to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for omega therapeutics clinical trials to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for omega therapeutics pipeline to provide analysis

Correlation between past revenue and omega therapeutics pipeline search interest

There is not enough data for omega therapeutics pipeline to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for omega therapeutics pipeline to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for omega therapeutics OTX-2002 to provide analysis

Correlation between past revenue and omega therapeutics OTX-2002 search interest

There is not enough data for omega therapeutics OTX-2002 to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for omega therapeutics OTX-2002 to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for omega therapeutics hepatocellular carcinoma to provide analysis

Correlation between past revenue and omega therapeutics hepatocellular carcinoma search interest

There is not enough data for omega therapeutics hepatocellular carcinoma to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for omega therapeutics hepatocellular carcinoma to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for omega therapeutics OEC candidates to provide analysis

Correlation between past revenue and omega therapeutics OEC candidates search interest

There is not enough data for omega therapeutics OEC candidates to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for omega therapeutics OEC candidates to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for omega therapeutics alopecia to provide analysis

Correlation between past revenue and omega therapeutics alopecia search interest

There is not enough data for omega therapeutics alopecia to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for omega therapeutics alopecia to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Useful links and data for OMGA
Earnings date: 2024-03-07 After close
Company name: Omega Therapeutics Inc
Sector: Manufacturing
Company's website
Hypercharts
Yahoo Finance
MarketWatch
StockTwits
SEC Filings
SwaggyStocks
Latest articles

2025-03-07T09:57:15-05:00

SEC
SCHEDULE 13G/A Form - [Amend] Statement of Beneficial Ownership by Certain Investors - Omega Therapeutics, Inc. (0001850838) (Subject)

2025-02-24T16:48:46-05:00

SEC
8-K Form - Current report, items 1.01 and 3.01 - Omega Therapeutics, Inc. (0001850838) (Filer)

2025-02-14T16:59:27-05:00

SEC
8-K Form - Current report, items 1.01, 1.03, and 2.03 - Omega Therapeutics, Inc. (0001850838) (Filer)

2025-02-05T16:40:53-05:00

SEC
SCHEDULE 13D/A Form - [Amend] General Statement of Acquisition of Beneficial Ownership - Omega Therapeutics, Inc. (0001850838) (Subject)

2025-02-05T15:57:47-05:00

SEC
144 Form - Report of proposed sale of securities - Omega Therapeutics, Inc. (0001850838) (Subject)

2025-02-04T21:59:03-05:00

SEC
3 Form - Initial statement of beneficial ownership of securities - Omega Therapeutics, Inc. (0001850838) (Issuer)

2025-02-03T17:05:51-05:00

SEC
8-K Form - Current report, items 1.01, 1.02, 2.03, 3.01, 5.02, and 8.01 - Omega Therapeutics, Inc. (0001850838) (Filer)

2025-01-23T06:00:00-05:00

PR Newswire
Flagship Pioneering, Cambridge University Health Partners, and Milner Therapeutics Institute Announce Collaboration to Accelerate Biotech Research and Innovation

2025-01-23T06:00:00-05:00

PR Newswire
Flagship Pioneering, Cambridge University Health Partners, and Milner Therapeutics Institute Announce Collaboration to Accelerate Biotech Research and Innovation

2024-11-20T08:00:00-05:00

PR Newswire
Flagship Pioneering Appoints Angela Hwang as CEO-Partner and Chief Executive Officer of Metaphore Biotechnologies

2024-11-20T06:30:00-05:00

PR Newswire
Flagship Pioneering Announces Two New Agreements with Ampersand Biomedicines and Montai Therapeutics Under its Strategic Partnership with Pfizer

2024-11-15T18:09:18-05:00

SEC
4 Form - Statement of changes in beneficial ownership of securities - Omega Therapeutics, Inc. (0001850838) (Issuer)

2024-11-15T12:45:21Z

Analyst Upgrades
Piper Sandler Maintains Overweight on Omega Therapeutics, Lowers Price Target to $4

2024-11-14T16:16:06-05:00

SEC
8-K Form - Current report, items 1.01, 5.02, 8.01, and 9.01 - Omega Therapeutics, Inc. (0001850838) (Filer)

2024-11-14T21:05:00Z

GlobeNewswire
Omega Therapeutics Announces Successful Completion of Phase 1 Trial for Novel Epigenomic Controller, Prioritized Pipeline, Leadership Changes, and Third Quarter 2024 Financial Results